Protein Cereblon (CRBN) Antibody

Product Graph
169€ (20 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Protein Cereblon (CRBN) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx322665
tested applications
ELISA, WB, IHC

Description

CRBN Antibody is a Rabbit Polyclonal against CRBN.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Protein Cereblon (CRBN)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/1000 - 1/5000, IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
20 µl
Size 2
50 µl
Size 3
100 µl
Size 4
200 µl
Size 5
1 ml
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, containing 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q96SW2
Gene ID
51185
NCBI Accession
NP_001166953.1, NM_001173482.1, NP_057386.2, NM_016302.3
OMIM
607417
Background
Antibody anti-CRBN
Status
RUO
Note
Concentration: 2 mg/ml -

Descripción

Related Products

EH1457

Human CRBN (Protein cereblon) ELISA Kit

Ver Producto
FNab01954

CRBN antibody

Substrate recognition component of a DCX(DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. May play a role in memory and learning by regulating the assembly and neuronal surface expression of large-conductance calcium-activated potassium channels in brain regions involved in memory and learning via its interaction with KCNT1. Binding of pomalidomide and other thalidomide-related drugs changes the substrate specificity of the human protein, leading to decreased degradation of MEIS2 and other target proteins and increased degradation of MYC, IRF4, IKZF1 and IKZF3.

Ver Producto
P0615

Recombinant Human CRBN

Ver Producto